Literature DB >> 10369924

The central MHC gene IKBL carries a structural polymorphism that is associated with HLA-A3,B7,DR15.

R J Allcock1, F T Christiansen, P Price.   

Abstract

Susceptibility to several disorders, including insulin-dependent diabetes mellitus and multiple sclerosis, has been associated with alleles of HLA class II genes and loci in the TNF cluster in the central major histocompatibility complex (MHC) region. As recombination within this region is rare, it is difficult to determine which genes are important. This will be facilitated by the identification of functional polymorphisms. Hence we are sequencing reverse transcription-polymerase chain reaction products derived from central MHC genes in well characterized and conserved ancestral haplotypes. Here we address the IKBL gene, which lies near the TNF cluster at the telomeric end of the central MHC. Although the IKBL cDNA sequence was conserved between most ancestral haplotypes, a synonymous nucleotide substitution, a 3' untranslated region substitution, and a single nonsynonymous substitution were identified. The latter (IKBL+738) was present in multiple examples of the 7.1 haplotype [HLA-A3, B7, DR2 (DR15)] and resulted in a cysteine to arginine substitution in a predicted protein kinase C phosphorylation site. This polymorphism did not occur in 18 other common haplotypes from the 10th International Histocompatibility Workshop and thus appears haplospecific. A role for IKBL+738 in the association between HLA-A3,B7,DR2(DR15) and susceptibility to multiple sclerosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369924     DOI: 10.1007/s002510050662

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  6 in total

1.  Patterns of linkage disequilibrium in the MHC region on human chromosome 6p.

Authors:  Annette Stenzel; Timothy Lu; W Andreas Koch; Jochen Hampe; Simone M Guenther; Francisco M De La Vega; Michael Krawczak; Stefan Schreiber
Journal:  Hum Genet       Date:  2004-01-22       Impact factor: 4.132

2.  Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis.

Authors:  Koichi Okamoto; Satoshi Makino; Yoko Yoshikawa; Asumi Takaki; Yumie Nagatsuka; Masao Ota; Gen Tamiya; Akinori Kimura; Seiamak Bahram; Hidetoshi Inoko
Journal:  Am J Hum Genet       Date:  2002-12-31       Impact factor: 11.025

3.  Correlation between visual acuity and human leukocyte antigen DRB1*04 in patients with Vogt-Koyanagi-Harada disease.

Authors:  Norihiko Misawa; Mizuki Tagami; Takeya Kohno; Shigeru Honda
Journal:  BMC Ophthalmol       Date:  2019-11-07       Impact factor: 2.209

4.  Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.

Authors:  Denise L Faustman; Limei Wang; Yoshiaki Okubo; Douglas Burger; Liqin Ban; Guotong Man; Hui Zheng; David Schoenfeld; Richard Pompei; Joseph Avruch; David M Nathan
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

5.  Chromatin profiling across the human tumour necrosis factor gene locus reveals a complex, cell type-specific landscape with novel regulatory elements.

Authors:  Jennifer M Taylor; Kate Wicks; Claire Vandiedonck; Julian C Knight
Journal:  Nucleic Acids Res       Date:  2008-07-24       Impact factor: 16.971

6.  Complex genetic predisposition in adult and juvenile rheumatoid arthritis.

Authors:  Bianca Miterski; Susanne Drynda; Gundula Böschow; Wolfram Klein; Joachim Oppermann; Jörn Kekow; Jörg Thomas Epplen
Journal:  BMC Genet       Date:  2004-02-04       Impact factor: 2.797

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.